Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan

Benedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, Ib Jarle Christensen, Kirsten Grunnet, Michael R Horsman, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Ulrik Lassen

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan'. Together they form a unique fingerprint.

Medicine & Life Sciences